Top compounds associated with response to RD3


Feature Type Standardized
Nominal ANOVA
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.075 0.02
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.081 0.02
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.079 0.02
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.075 0.02
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.073 0.03
mRNA LFM-A13 GDSC1000 pan-cancer AAC -0.076 0.03
mRNA RO-3306 GDSC1000 pan-cancer AAC -0.075 0.03
Download CSV